Clinical trial
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular…
NCT00489944 · San Diego Pacific Oncology & Hematology Associates, Other · Unknown status
Key facts
| NCT number | NCT00489944 |
|---|---|
| Title | Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma |
| Official title | A Phase II Pilot Trial of Sutent, Tamoxifen, and Cisplatin in Patients With High-Risk Ocular Melanoma |
| Lead sponsor | San Diego Pacific Oncology & Hematology Associates, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intraocular Melanoma |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, sunitinib malate, tamoxifen citrate, adjuvant therapy |
| Enrollment | 50 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2012 |
| First posted | Jun 21, 2007 |
| Last update posted | Jan 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: